A Phase I/II Trial of Intensity Modulated Radiation (IMRT) Dose Escalation With Concurrent Fixed-dose Rate Gemcitabine (FDR-G) in Patients With Unresectable Pancreatic Cancer-Reference-Cited by-同舟云学术

A Phase I/II Trial of Intensity Modulated Radiation (IMRT) Dose Escalation With Concurrent Fixed-dose Rate Gemcitabine (FDR-G) in Patients With Unresectable Pancreatic Cancer

Published:2012-12 Issue:5 Volume:84 Page:1166-1171
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Ben-Josef Edgar,Schipper Mathew,Francis Isaac R.,Hadley Scott,Ten-Haken Randall,Lawrence Theodore,Normolle Daniel,Simeone Diane M.,Sonnenday Christopher,Abrams Ross,Leslie William,Khan Gazala,Zalupski Mark M.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference20 articles.

1. Full-dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer;Murphy;Int J Radiat Oncol Biol Phys,2007

2. DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer;Iacobuzio-Donahue;J Clin Oncol,2009

3. A randomized phase III study of gemcitabine in combination with radiation therapy versus gemcitabine alone in patients with localized, unresectable pancreatic cancer: E4201;Loehrer;J Clin Oncol,2008

4. Feasibility and efficacy of high dose conformal radiotherapy for patients with locally advanced pancreatic carcinoma;Ceha;Cancer,2000

5. Radiosensitization of pancreatic cancer cells by 2′,2′-difluoro-2′-deoxycytidine;Lawrence;Int J Radiat Oncol Biol Phys,1996

Cited by 166 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MR-linac based radiation therapy in gastrointestinal cancers: a narrative review;Journal of Gastrointestinal Oncology;2024-08

2. Standard or High Dose Chemoradiotherapy, with or Without the Protease Inhibitor Nelfinavir, for the Treatment of Locally Advanced Pancreatic Cancer: Efficacy, Safety and Health-Related Quality of Life Outcomes from the Multi-Centre Two Stage Phase 1/Randomised Phase 2 SCALOP-2 Study;2024

3. MR-Guided Radiation Therapy With Concurrent Gemcitabine/Nab-Paclitaxel Chemotherapy in Inoperable Pancreatic Cancer: A TITE-CRM Phase I Trial;International Journal of Radiation Oncology*Biology*Physics;2023-01

4. Pancreatic Cancer;Target Volume Definition in Radiation Oncology;2023

5. Implementation of the Time-to-Event Continuous Reassessment Method Design in a Phase I Platform Trial Testing Novel Radiotherapy-Drug Combinations—CONCORDE;JCO Precision Oncology;2022-11